Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech, Indications -- Ignore unavailable to you. Want to Upgrade?

To: tnsaf who wrote (13)	7/12/1999 12:03:00 AM
From: LLCF	Read Replies (1) \| Respond to of 22

<Can someone tell me what differences there are between Ph1, 1a and 1b? Also Ph2, 2a and 2b?> You could check over here: Subject 24607 DAK

To: tnsaf who wrote (13)	7/12/1999 12:19:00 AM
From: LLCF	Respond to of 22

PSORIASIS: <One notable omission from your list is MEDI-507 entering Ph1 for psoriasis in 4/99.> So here's how the thread is supposed to work... you put the header up there, so everyone sees the indication you're updating, and people don't have to schag through lots of posts to find what they're looking for. Then you're message and what you're doing [this dibble I've written] then copy the last indication you saw on the thread and make your addition: Indication: Psoriasis Market: Small, Moderate, Giant Approved competition: Weak, Moderate, Strong Clinical [pre-clinic?] competition: Ligands's *retins, and Ontak, Ph? Abgenix anti-IL8 human antibody Ph? ICOS's anti-ICAM-3 antibody Vertex small molecule inhibitor of T-cell proliferation Axys tryptase small molecule inhibitor IDEC's anti-B7 and (maybe??) anti-CD4 antibodies ... Biogen's Amevive, phIIb Xoma Hu1124, Anti-CD11a antibody, Ph2 ISIS 2302 (ICAM-1 inhibitor) MEDI-507 [new PH1, 4/99] also in ph2 for organ rejection. Worthwhile links: Message 10418030 recap.com Then the next person does the same and on and on... this way we have updated info... commentary on each would be a bonus also.. notice I'm hoping someone jump in and fill in market size for the indications, etc... DAK DAK